Deficiency of adenosine deaminase 2 skews adaptive immune repertoires toward specific sets of T- and B-cell receptors
Journal of Allergy and Clinical Immunology · 2025
DOI: 10.1016/j.jaci.2025.01.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Christoph Schultheiß und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, University Hospital Basel, Basel, Switzerland; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, …. Hauptthemen laut MEDLINE: Adenosine Deaminase, Adaptive Immunity, Receptors, Antigen, B-Cell, T-Lymphocytes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Swiss National Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Adenosine deaminase 2 deficiency (DADA2) is a genetic disorder caused by biallelic hypomorphic or loss-of-function mutations in the ADA2 gene, which encodes a protein deaminase regulating extracellular adenosine metabolism. Clinical features encompass inflammatory vasculopathy, early-onset strokes, and a complex presentation involving both immunodeficiency and autoinflammation/autoimmunity. OBJECTIVE: Our aim was to determine a DADA2-specific adaptive immune architecture. METHODS: We profiled immunoglobulin levels and peripheral B- and T-cell phenotypes in 47 previously reported and 5 unreported patients with DADA2. Levels of 21 cytokines and chemokines were quantified in patients with or without anti-TNF treatment. To characterize the DADA2 immune architecture, we performed T- and B-cell receptor immunosequencing. We trained a binary LightGBM classifier to distinguish DADA2 T- and B-cell immune repertoires from healthy individuals. RESULTS: We detected hypogammaglobulinemia in 65% of patients with DADA2 (34 of 52) and cytopenias in 48% (25 of 52). Flow cytometric profiling revealed contraction of B- and T-cell memory compartments. In addition, we observed elevated levels of TNF, IL-8, several interferons, a proliferation-inducing ligand (APRIL), B-cell activating factor (BAFF), and soluble CD40 ligand (sCD40L). High serum levels of TNF, BAFF, and sCD40L persisted under anti-TNF therapy. Next-generation immunosequencing of peripheral lymphocytes showed restricted T-cell receptor repertoires and B cells, which were particularly skewed toward immunoglobulin heavy chain V4-34 rearrangements. With high accuracy, our machine learning algorithm separated individuals with DADA2 from healthy individuals on the basis of immunogenetic parameters regarding B-cell clone fraction, CDR3 length, and selected Kidera factors. CONCLUSIONS: Our findings underscore the significant influence of ADA2 on the adaptive immune system, which results in a highly specific immunogenetic signature in patients with DADA2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, University Hospital Basel, Basel, Switzerland; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel; Basel, Switzerland.
- Division of Medical Oncology, University Hospital Basel, Basel, Switzerland; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel; Basel, Switzerland; Collabor…
- Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
- Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, Md.
- Institute for Medical Epidemiology, Biometrics and Informatics, Interdisciplinary Centre for Health Sciences, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Swiss National Science Foundation
Zitieren
APA
Schultheiß, C., Schmidt-Barbo, P., Paschold, L., Esperanzate, C., Behn, A., Mikolajczyk, R., Kastner, D. L., Aksentijevich, I., & Binder, M. (2025). Deficiency of adenosine deaminase 2 skews adaptive immune repertoires toward specific sets of T- and B-cell receptors. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.01.032
Vancouver
Schultheiß C, Schmidt-Barbo P, Paschold L, Esperanzate C, Behn A, Mikolajczyk R, et al. Deficiency of adenosine deaminase 2 skews adaptive immune repertoires toward specific sets of T- and B-cell receptors. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.01.032
BibTeX
@article{Schulthei2025,
author = {Schultheiß, Christoph and Schmidt-Barbo, Paul and Paschold, Lisa and Esperanzate, Carl and Behn, Alissa and Mikolajczyk, Rafael and Kastner, Daniel L and Aksentijevich, Ivona and Binder, Mascha},
title = {Deficiency of adenosine deaminase 2 skews adaptive immune repertoires toward specific sets of T- and B-cell receptors},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
doi = {10.1016/j.jaci.2025.01.032}
}
EUVIMED